These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33971044)

  • 1. Dramatic response to encorafenib in a patient with Erdheim-Chester disease harboring the BRAF
    Wada F; Hiramoto N; Yamashita D; Hara S; Furukawa Y; Ishii J; Nagata K; Nannya Y; Ogawa S; Ishikawa T
    Am J Hematol; 2021 Aug; 96(8):E295-E298. PubMed ID: 33971044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erdheim-Chester disease].
    Mazor RD; Shoenfeld Y
    Harefuah; 2014 Jul; 153(7):389-91, 434, 433. PubMed ID: 25189027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose vemurafenib monotherapy in
    Ruan GJ; Hazim A; Abeykoon JP; Scheckel C; Vassallo R; Ryu JH; Tobin WO; Koster MJ; Bennani NN; Rech KL; Young JR; Shah MV; Goyal G; Go RS
    Leuk Lymphoma; 2020 Nov; 61(11):2733-2737. PubMed ID: 32608295
    [No Abstract]   [Full Text] [Related]  

  • 4. A cytologic diagnosis of BRAF
    Chasseur P; Kyriakopoulou M; Vokaer B; Beukinga I; Casado Arroyo R; Cogan E; Couturier B
    Acta Clin Belg; 2017 Oct; 72(5):369-371. PubMed ID: 28222655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
    Haroche J; Cohen-Aubart F; Emile JF; Arnaud L; Maksud P; Charlotte F; Cluzel P; Drier A; Hervier B; Benameur N; Besnard S; Donadieu J; Amoura Z
    Blood; 2013 Feb; 121(9):1495-500. PubMed ID: 23258922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation.
    Al-Salama ZT
    Drugs; 2021 May; 81(7):849-856. PubMed ID: 33914242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erdheim-Chester disease harboring the BRAF V600E mutation.
    Blombery P; Wong SQ; Lade S; Prince HM
    J Clin Oncol; 2012 Nov; 30(32):e331-2. PubMed ID: 23008323
    [No Abstract]   [Full Text] [Related]  

  • 8. Saving orphans: BRAF targeting of histiocytosis.
    Heaney ML
    Blood; 2013 Feb; 121(9):1487-8. PubMed ID: 23449613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoalphalipoproteinemia and BRAF
    Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encorafenib and binimetinib for the treatment of BRAF V600E/K-mutated melanoma.
    Rose AAN
    Drugs Today (Barc); 2019 Apr; 55(4):247-264. PubMed ID: 31050693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
    Haroche J; Cohen-Aubart F; Emile JF; Maksud P; Drier A; Tolédano D; Barete S; Charlotte F; Cluzel P; Donadieu J; Benameur N; Grenier PA; Besnard S; Ory JP; Lifermann F; Idbaih A; Granel B; Graffin B; Hervier B; Arnaud L; Amoura Z
    J Clin Oncol; 2015 Feb; 33(5):411-8. PubMed ID: 25422482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAF
    Hartman ML; Gajos-Michniewicz A; Talaj JA; Mielczarek-Lewandowska A; Czyz M
    Cancer Lett; 2021 Feb; 499():122-136. PubMed ID: 33259900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective treatment in Erdheim Chester disease: vemurafenib: a case report.
    Bozan E; Darçın T; Yaman S; Yiğenoğlu TN; Kızıl Çakar M; Dal MS; Altuntaş F
    J Med Case Rep; 2023 Oct; 17(1):426. PubMed ID: 37821987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drug approval: Encorafenib-metastatic colorectal cancers with BRAF V600E mutation after systemic chemotherapy].
    Boilève A; Samalin E
    Bull Cancer; 2020 Nov; 107(11):1086-1088. PubMed ID: 33046237
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAF
    Pieri V; Berzero G; Paterra R; Ferré L; Tomelleri A; Campochiaro C; Esposito F; Calimeri T; Cangi MG; Tenace NP; Ferreri AJM; Castellano A; Barbera M; Anzalone N; Gay LG; Bello L; Colecchia M; Ponzoni M; Finocchiaro G; Filippi M
    J Neurol; 2024 Jan; 271(1):575-579. PubMed ID: 37725109
    [No Abstract]   [Full Text] [Related]  

  • 17. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAF
    Nikpanah M; Kim L; Mirmomen SM; Symons R; Papageorgiou I; Gahl WA; O'Brien K; Estrada-Veras JI; Malayeri AA
    Eur Radiol; 2018 Sep; 28(9):3751-3759. PubMed ID: 29556768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
    Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
    J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Erdheim-Chester disease with the
    Matsuhisa T; Teranishi M; Tsuyuki Y; Sone M; Sato J
    Nagoya J Med Sci; 2023 Feb; 85(1):150-156. PubMed ID: 36923612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAF
    Mirmomen SM; Sirajuddin A; Nikpanah M; Symons R; Paschall AK; Papageorgiou I; Gahl WA; O'Brien K; Estrada-Veras JI; Malayeri AA
    Eur Radiol; 2018 Nov; 28(11):4635-4642. PubMed ID: 29736852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.